Changes in vaginal microbiota and immune mediators in HIV-1-seronegative Kenyan women initiating depot medroxyprogesterone acetate

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 4, 2016, Pages 359-366

  Roxby, Alison C ^a   Fredricks, David N ^a,b,c   Odem Davis, Katherine ^a   Ásbjörnsdóttir, Kristjana ^a   Masese, Linnet ^a   Fiedler, Tina L ^c   De Rosa, Stephen ^b,c   Jaoko, Walter ^d   Kiarie, James N ^a,e,f   Overbaugh, Julie ^c   Scott McClelland, R ^a  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Departments of Medical Microbiology   (Kenya)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f KENYATTA NATIONAL HOSPITAL   (Kenya)

Author keywords

Bacterial vaginosis; Depot medroxyprogesterone actetate; DMPA; Gardnerella vaginalis; HIV 1 susceptibility; IL 1 receptor antagonist; IL 6; IL 8; Lactobacillus; Vaginal microbiota

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MEDROXYPROGESTERONE ACETATE; BACTERIAL RNA; CONTRACEPTIVE AGENT; DELAYED RELEASE FORMULATION; RNA 16S;

ADULT; BACTERIAL LOAD; BACTERIUM DETECTION; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GARDNERELLA VAGINALIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; KENYAN; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS INERS; LACTOBACILLUS JENSENII; MICROBIAL COMMUNITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RNA GENE; VAGINA FLORA; VAGINITIS; BACTERIUM; DELAYED RELEASE FORMULATION; DRUG EFFECTS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; ISOLATION AND PURIFICATION; KENYA; MICROBIOLOGY; SERODIAGNOSIS; VAGINA;

ADULT; BACTERIA; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; FEMALE; HIV SERONEGATIVITY; HIV-1; HUMANS; KENYA; MEDROXYPROGESTERONE ACETATE; PROSPECTIVE STUDIES; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; VAGINA;

EID: 84960370240     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000866     Document Type: Conference Paper

References (41)

1. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis. 2012;12:19-26.
2. Baeten JM, Benki S, Chohan V, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS. 2007;21:1771-1777.
3. Morrison CS, Chen PL, Kwok C, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS. 2010; 24:1778-1781.
4. Polis CB, Phillips SJ, Curtis KM, et al. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception. 2014;90:360-390.
5. PEPFAR. PEPFAR 3.0: Controlling the Epidemic: Delivering on the Promise of an AIDS-Free Generation. Washington, DC: The Office of the U.S. Global AIDS Coordinator; 2014.
6. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol. 2001;185:380-385.
7. Pettifor A, Delany S, Kleinschmidt I, et al. Use of injectable progestin contraception and risk of STI among South African women. Contraception. 2009;80:555-560.
8. McClelland RS, Richardson BA, Graham SM, et al. A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sex Transm Dis. 2008;35:617-623.
9. Jespers V, Crucitti T, Menten J, et al. Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study. PLoS One. 2014;9:e109670.
10. Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22: 1493-1501.
11. Myer L, Denny L, Telerant R, et al. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis. 2005;192:1372-1380.
12. van de Wijgert JH, Borgdorff H, Verhelst R, et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One. 2014;9:e105998.
13. Bukusi EA, Cohen CR, Meier AS, et al. Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis. 2006; 33:361-367.
14. Martin HL Jr, Nyange PM, Richardson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1998;178:1053-1059.
15. Achilles SL, Hillier SL. The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. AIDS. 2013; 27(suppl 1):S5-S15.
16. Graham SM, Jalalian-Lechak Z, Shafi J, et al. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA. J Acquir Immune Defic Syndr. 2012;60:511-518.
17. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301.
18. Fredricks DN, Fiedler TL, Thomas KK, et al. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol. 2007;45:3270-3276.
19. Khot PD, Ko DL, Hackman RC, et al. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis. 2008;8:73.
20. Fredricks DN, Fiedler TL, Thomas KK, et al. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol. 2009;47:721-726.
21. Srinivasan S, Liu C, Mitchell CM, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One. 2010;5:e10197.
22. Srinivasan S, Hoffman NG, Morgan MT, et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One. 2012;7:e37818.
23. Baeten JM, Hassan WM, Chohan V, et al. Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronega-tive women. Sex Transm Infect. 2009;85:348-353.
24. McClelland RS, Richardson BA, Hassan WM, et al. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis. 2008;197:1361-1368.
25. Rifkin SB, Smith MR, Brotman RM, et al. Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD. Contraception. 2009;80:63-67.
26. Riggs M, Klebanoff M, Nansel T, et al. Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis. 2007;34:954-959.
27. Santiago GL, Tency I, Verstraelen H, et al. Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina. PLoS One. 2012;7:e45281.
28. Mitchell CM, McLemore L, Westerberg K, et al. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. J Infect Dis. 2014;210:651-655.
29. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180: 1863-1868.
30. van de Wijgert JH, Morrison CS, Cornelisse PG, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2008;48: 203-210.
31. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12:1699-1706.
32. Mirmonsef P, Gilbert D, Zariffard MR, et al. The effects of commensal bacteria on innate immune responses in the female genital tract. Am J Reprod Immunol. 2011;65:190-195.
33. Verstraelen H, Verhelst R, Claeys G, et al. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 2009;9:116.
34. Hummelen R, Fernandes AD, Macklaim JM, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One. 2010;5:e12078.
35. De Backer E, Verhelst R, Verstraelen H, et al. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol. 2007;7:115.
36. Macklaim JM, Gloor GB, Anukam KC, et al. At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci USA. 2011;108(suppl 1):4688-4695.
37. Govender Y, Avenant C, Verhoog NJ, et al. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor. PLoS One. 2014;9:e96497.
38. Chandra N, Thurman AR, Anderson S, et al. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses. 2013;29:592-601.
39. Ildgruben AK, Sjoberg IM, Hammarstrom ML. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet Gynecol. 2003;102:571-582.
40. Morrison C, Fichorova RN, Mauck C, et al. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion. J Acquir Immune Defic Syndr. 2014;66:109-117.
41. Orfanelli T, Jayaram A, Doulaveris G, et al. Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition. Reprod Sci. 2014;21:538-542.